Amedeo Smart

Free Medical Literature Service

 

Amedeo

Arrhythmias
  Free Subscription

Articles published in
Circulation
    December 2024
  1. O'NEILL MJ, Ng CA, Aizawa T, Sala L, et al
    Multiplexed Assays of Variant Effect and Automated Patch Clamping Improve KCNH2-LQTS Variant Classification and Cardiac Event Risk Stratification.
    Circulation. 2024;150:1869-1881.
    >> Share

    November 2024
  2. HAUGUEL-MOREAU M, Guedeney P, Dauphin C, Auffret V, et al
    Flecainide to Prevent Atrial Arrhythmia After Patent Foramen Ovale Closure: AFLOAT Study, A Randomized Clinical Trial.
    Circulation. 2024;150:1659-1668.
    >> Share

  3. LUCIJANIC M, Krecak I
    Letter by Lucijanic and Krecak Regarding Article, "Clonal Hematopoiesis of Indeterminate Potential With Loss of Tet2 Enhances Risk for Atrial Fibrillation Through Nlrp3 Inflammasome Activation".
    Circulation. 2024;150:e447-e448.
    >> Share

    October 2024
  4. STIEGLIS R, Verkaik BJ, Tan HL, Koster RW, et al
    Association Between Delay to First Shock and Successful First-Shock Ventricular Fibrillation Termination in Patients With Witnessed Out-of-Hospital Cardiac Arrest.
    Circulation. 2024 Oct 27. doi: 10.1161/CIRCULATIONAHA.124.069834.
    >> Share

  5. SOHNS C, Sommer P
    Patients With Advanced Heart Failure and Atrial Fibrillation Deserve an Attempt at Catheter Ablation as First-Line Therapy.
    Circulation. 2024;150:1220-1222.
    >> Share

  6. GOPINATHANNAIR R, Olshansky B, Chung MK, Gordon S, et al
    Cardiac Arrhythmias and Autonomic Dysfunction Associated With COVID-19: A Scientific Statement From the American Heart Association.
    Circulation. 2024 Oct 14. doi: 10.1161/CIR.0000000000001290.
    >> Share

  7. ALDAAS OM, Aldaas AM, Hsu JC
    Letter by Aldaas et al Regarding Article, "Direct Oral Anticoagulants for Stroke Prevention in Patients With Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials".
    Circulation. 2024;150:e273.
    >> Share

  8. MCINTYRE WF, Benz AP, Healey JS, Lopes R, et al
    Response by McIntyre et al to Letter Regarding Article, "Direct Oral Anticoagulants for Stroke Prevention in Patients With Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials".
    Circulation. 2024;150:e274-e275.
    >> Share

  9. BORTOLIN RH, Nawar F, Park C, Trembley MA, et al
    Antisense Oligonucleotide Therapy for Calmodulinopathy.
    Circulation. 2024;150:1199-1210.
    >> Share

  10. SCHMIDT B, Bordignon S, Metzner A, Sommer P, et al
    Ablation Strategies for Repeat Procedures in Atrial Fibrillation Recurrences Despite Durable Pulmonary Vein Isolation: The Prospective Randomized ASTRO AF Multicenter Trial.
    Circulation. 2024 Oct 7. doi: 10.1161/CIRCULATIONAHA.124.069993.
    >> Share

    September 2024
  11. FRIEDMAN P, Murgatroyd F, Boersma LVA, Manlucu J, et al
    Performance and Safety of the Extravascular Implantable Cardioverter-Defibrillator Through Long-Term Follow-Up: Final Results From the Pivotal Study.
    Circulation. 2024 Sep 26. doi: 10.1161/CIRCULATIONAHA.124.071795.
    >> Share

  12. RAJENDRAN K, Alphonse AJ, Desabandhu V
    ECG Changes in a Patient With Recurrent Palpitations.
    Circulation. 2024;150:1061-1063.
    >> Share

  13. LI J, Janin A, Patoughi M, Gaudreault N, et al
    Circulating Autoantibodies Targeting TREK-1 in Patients With Short-Coupled Ventricular Fibrillation.
    Circulation. 2024 Sep 24. doi: 10.1161/CIRCULATIONAHA.124.070284.
    >> Share

  14. REDDY VY, Calkins H, Mansour M, Wazni O, et al
    Pulsed Field Ablation to Treat Paroxysmal Atrial Fibrillation: Safety and Effectiveness in the ADMIRE Pivotal Trial.
    Circulation. 2024 Sep 11. doi: 10.1161/CIRCULATIONAHA.124.070333.
    >> Share

  15. MCINTYRE WF, Benz AP, Healey JS, Connolly SJ, et al
    Risk of Stroke or Systemic Embolism According to Baseline Frequency and Duration of Subclinical Atrial Fibrillation: Insights From the ARTESiA Trial.
    Circulation. 2024 Sep 4. doi: 10.1161/CIRCULATIONAHA.124.069903.
    >> Share

  16. KEMP GUDMUNDSDOTTIR K, Svennberg E, Friberg L, Hygrell T, et al
    Randomized Invitation to Systematic NT-proBNP and ECG Screening in 75-Year Olds to Detect Atrial Fibrillation -STROKESTOP II.
    Circulation. 2024 Sep 1. doi: 10.1161/CIRCULATIONAHA.124.071176.
    >> Share

    August 2024
  17. SOHNS C, Moersdorf M, Marrouche NF, Bergau L, et al
    Catheter Ablation in Patients with End-Stage Heart Failure and Atrial Fibrillation: Two-year Follow-up of the CASTLE-HTx Trial.
    Circulation. 2024 Aug 30. doi: 10.1161/CIRCULATIONAHA.124.071517.
    >> Share

  18. VISKIN S, Chorin E, Rosso R, Amin AS, et al
    Diagnosis of Brugada Syndrome With a Sodium-Channel-Blocker Test: Who Should Be Tested? Who Should Not?
    Circulation. 2024;150:642-650.
    >> Share

  19. KOBAYASHI H, Tohyama S, Ichimura H, Ohashi N, et al
    Regeneration of Nonhuman Primate Hearts With Human Induced Pluripotent Stem Cell-Derived Cardiac Spheroids.
    Circulation. 2024;150:611-621.
    >> Share

  20. AL SAYED ZR, Pereira C, Le Borgne R, Viaris de Lesegno C, et al
    CAVIN1-Mediated hERG Dynamics: A Novel Mechanism Underlying the Interindividual Variability in Drug-Induced Long QT.
    Circulation. 2024;150:563-576.
    >> Share

  21. MARCUS MD, Link MS
    Omega-3 Fatty Acids and Arrhythmias.
    Circulation. 2024;150:488-503.
    >> Share

  22. MONDAL S, Abhilash SP, Namboodiri N
    Recognition of an Unusual Pattern in a Case of Narrow Complex Tachycardia.
    Circulation. 2024;150:506-508.
    >> Share

  23. SVEDBERG N, Sundstrom J, James S, Hallmarker U, et al
    Long-Term Incidence of Bradycardia and Pacemaker Implantations Among Cross-Country Skiers: A Cohort Study.
    Circulation. 2024 Aug 5. doi: 10.1161/CIRCULATIONAHA.123.068280.
    >> Share

    July 2024
  24. LAMBIASE PD, van Duijvenboden S
    Response by Lambiase and van Duijvenboden to Letter Regarding Article, "Prognostic Significance of Different Ventricular Ectopic Burdens During Submaximal Exercise in Asymptomatic UK Biobank Subjects".
    Circulation. 2024;150:e104.
    >> Share

  25. KATSOURAS CS
    Letter by Katsouras Regarding Article, "Prognostic Significance of Different Ventricular Ectopic Burdens During Submaximal Exercise in Asymptomatic UK Biobank Subjects".
    Circulation. 2024;150:e102-e103.
    >> Share

  26. LAMPERT R, Day S, Ainsworth B, Burg M, et al
    Vigorous Exercise in Patients With Congenital Long-QT Syndrome: Results of the Prospective, Observational, Multinational LIVE-LQTS Study.
    Circulation. 2024 Jul 25. doi: 10.1161/CIRCULATIONAHA.123.067590.
    >> Share

  27. AULIN J, Sjolin K, Lindback J, Benz AP, et al
    Neurofilament Light Chain and Risk of Stroke in Patients With Atrial Fibrillation.
    Circulation. 2024 Jul 24. doi: 10.1161/CIRCULATIONAHA.124.069440.
    >> Share

  28. WAN EY, Rogers AJ, Lavelle M, Marcus M, et al
    Periprocedural Management and Multidisciplinary Care Pathways for Patients With Cardiac Implantable Electronic Devices: A Scientific Statement From the American Heart Association.
    Circulation. 2024 Jul 10. doi: 10.1161/CIR.0000000000001264.
    >> Share

  29. HEIJMAN J, Dobrev D
    Spexin Hormone Signaling and Atrial Fibrillation: The Knowns and Unknowns.
    Circulation. 2024;150:128-131.
    >> Share

  30. VAN DOORN S, Rutten FH, Geersing GJ
    Response by van Doorn et al to Letters Regarding Article, "Safety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled
    Circulation. 2024;150:e30-e32.
    >> Share

  31. KO D, Kim DH, Singer DE
    Letter by Ko et al Regarding Article, "Safety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial".
    Circulation. 2024;150:e25-e26.
    >> Share

  32. SUWA M, Morii I, Kino M
    Letter by Suwa et al Regarding Article, "Safety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial".
    Circulation. 2024;150:e27.
    >> Share

  33. MILLIS CE, Feradov DF, Prida XE
    Letter by Millis et al Regarding Article, "Safety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial".
    Circulation. 2024;150:e23-e24.
    >> Share

  34. LIN Y
    Letter by Lin Regarding Article, "Safety of Switching from a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients with Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial".
    Circulation. 2024;150:e21-e22.
    >> Share

  35. KOHSAKA S, Nishimura S, Kumamaru H
    Letter by Kohsaka et al Regarding Article, "Safety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial".
    Circulation. 2024;150:e28-e29.
    >> Share

  36. ORAL H, Morady F
    Ablation of Cardiac Arrhythmias: Past, Present, and Future.
    Circulation. 2024;150:4-6.
    >> Share


  37. Correction to: Early Versus Late Initiation of Direct Oral Anticoagulants After Ischemic Stroke in People With Atrial Fibrillation and Hemorrhagic Transformation: Prespecified Subanalysis of the Randomized Controlled ELAN Trial.
    Circulation. 2024;150:e20.
    >> Share

    June 2024
  38. PEIGH G, Zhou J, Rosemas SC, Roberts AI, et al
    Association of Atrial Fibrillation Burden and Mortality Among Patients With Cardiac Implantable Electronic Devices.
    Circulation. 2024 Jun 28. doi: 10.1161/CIRCULATIONAHA.124.069757.
    >> Share

  39. CROTTI L, Neves R, Dagradi F, Musu G, et al
    Therapeutic Efficacy of Mexiletine for Long QT Syndrome Type 2: Evidence From Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes, Transgenic Rabbits, and Patients.
    Circulation. 2024 Jun 28. doi: 10.1161/CIRCULATIONAHA.124.068959.
    >> Share

  40. FAKUADE FE, Hubricht D, Moller V, Sobitov I, et al
    Impaired Intracellular Calcium Buffering Contributes to the Arrhythmogenic Substrate in Atrial Myocytes From Patients With Atrial Fibrillation.
    Circulation. 2024 Jun 24. doi: 10.1161/CIRCULATIONAHA.123.066577.
    >> Share

  41. GROUSSIN P, Melot A, Martins RP
    PVC or Not PVC? That Is the Question.
    Circulation. 2024;149:1927-1930.
    >> Share


  42. Correction to: 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2024;149:e1413.
    >> Share

  43. LEE CH, Higgs E, Scheinman MM
    A Wide Complex Tachycardia.
    Circulation. 2024;149:1852-1854.
    >> Share

    May 2024
  44. ENSAM B, Scrocco C, Johnson D, Wijeyeratne YD, et al
    Type 1 Brugada Pattern May Be Provoked by Ajmaline in Some Healthy Subjects: Results From a Clinical Trial.
    Circulation. 2024;149:1693-1695.
    >> Share

  45. ROHNER R, Kneihsl M, Goeldlin MB, Hakim A, et al
    Early Versus Late Initiation of Direct Oral Anticoagulants After Ischemic Stroke in People With Atrial Fibrillation and Hemorrhagic Transformation: Prespecified Subanalysis of the Randomized-controlled ELAN Trial.
    Circulation. 2024 May 16. doi: 10.1161/CIRCULATIONAHA.124.069324.
    >> Share

  46. MAHESH M, Mantoo MR, Makkar N
    Left Ventricular Hypertrophy With Preexcitation.
    Circulation. 2024;149:1614-1616.
    >> Share

  47. LI D, Liu Y, Li C, Zhou Z, et al
    Spexin Diminishes Atrial Fibrillation Vulnerability by Acting on Galanin Receptor 2.
    Circulation. 2024 May 10. doi: 10.1161/CIRCULATIONAHA.123.067517.
    >> Share

    April 2024
  48. MAYER M
    Letter by Mayer Regarding Article, "Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants".
    Circulation. 2024;149:e1109-e1110.
    >> Share

  49. AGGARWAL R, Ruff CT, Virdone S, Perreault S, et al
    Response by Aggarwal et al to Letter Regarding Article, "Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants".
    Circulation. 2024;149:e1111-e1112.
    >> Share

  50. CHUGH SS
    Prevention of Sudden Cardiac Death: Beyond Automated External Defibrillators and Implantable Cardioverter Defibrillators.
    Circulation. 2024;149:1059-1061.
    >> Share

    March 2024
  51. PATEL SM, Ruff CT
    Subclinical Atrial Fibrillation and Anticoagulation: Weighing the Absolute Risks and Benefits.
    Circulation. 2024;149:989-992.
    >> Share

  52. REIFFEL JA
    Atrial Fibrillation: Why Are We Hiding Reality?
    Circulation. 2024;149:979-980.
    >> Share

  53. LEE CH, Scheinman MM
    Wide Complex Tachycardia: Mind Your Medicine!
    Circulation. 2024;149:963-966.
    >> Share

  54. KOWEY PR, Naccarelli GV
    Antiarrhythmic Drug Therapy: Where Do We Go From Here?
    Circulation. 2024;149:801-803.
    >> Share

  55. KLEIMAN NS, Goel SS
    The Shape of Things to Come? Is a Trial of Combined Interventional Procedures Necessary in Today's World?
    Circulation. 2024;149:744-746.
    >> Share

  56. BATRA AS, Silka MJ, Borquez A, Cuneo B, et al
    Pharmacological Management of Cardiac Arrhythmias in the Fetal and Neonatal Periods: A Scientific Statement From the American Heart Association: Endorsed by the Pediatric & Congenital Electrophysiology Society (PACES).
    Circulation. 2024;149:e937-e952.
    >> Share

    February 2024

  57. Correction to: 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2024;149:e936.
    >> Share

  58. HOEDEMAKERS S, Pugliese NR, Stassen J, Vanoppen A, et al
    mPAP/CO Slope and Oxygen Uptake Add Prognostic Value in Aortic Stenosis.
    Circulation. 2024 Feb 27. doi: 10.1161/CIRCULATIONAHA.123.067130.
    >> Share

  59. LIN AE, Bapat AC, Xiao L, Niroula A, et al
    Clonal Hematopoiesis of Indeterminate Potential With Loss of Tet2 Enhances Risk for Atrial Fibrillation Through Nlrp3 Inflammasome Activation.
    Circulation. 2024 Feb 15. doi: 10.1161/CIRCULATIONAHA.123.065597.
    >> Share

  60. SANCHEZ RH, Hamdan H, Torrealba J, Grodin JL, et al
    Giants Hiding in Small Places: A Case of New Onset Heart Failure, Atrioventricular Block, and Ventricular Arrhythmias.
    Circulation. 2024;149:475-480.
    >> Share

  61. GALEA R, Meneveau N, De Marco F, Aminian A, et al
    One-Year Outcomes After Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: A Prespecified Analysis of the SWISS-APERO Randomized Clinical Trial.
    Circulation. 2024;149:484-486.
    >> Share

    January 2024
  62. LEE SY, Lee BK
    Palpitations and Recurrent Syncope in a Young Woman.
    Circulation. 2024;149:402-405.
    >> Share

  63. HERWEG B, Sharma PS, Cano O, Ponnusamy SS, et al
    Arrhythmic Risk in Biventricular Pacing Compared With Left Bundle Branch Area Pacing: Results From the I-CLAS Study.
    Circulation. 2024;149:379-390.
    >> Share

  64. PATEL SM, Braunwald E, Steffel J, Boriani G, et al
    Efficacy and Safety of Non-Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of Four Randomized Clinical Trials of 58 464 Patients With Atrial Fibr
    Circulation. 2024 Jan 24. doi: 10.1161/CIRCULATIONAHA.123.066279.
    >> Share

  65. WALLENTIN L, Giugliano RP
    Switching to Direct Anticoagulation or Continued Vitamin-K Antagonists in Frail Patients With Atrial Fibrillation in Whom Vitamin-K Antagonists Are Tolerated?
    Circulation. 2024;149:290-292.
    >> Share

  66. BROMAN MT, Nadadur RD, Perez-Cervantes C, Burnicka-Turek O, et al
    A Genomic Link From Heart Failure to Atrial Fibrillation Risk: FOG2 Modulates a TBX5/GATA4-Dependent Atrial Gene Regulatory Network.
    Circulation. 2024 Jan 8. doi: 10.1161/CIRCULATIONAHA.123.066804.
    >> Share


  67. Correction to: 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2024;149:e167.
    >> Share

    December 2023
  68. OSTERGAARD L, Olesen JB, Petersen JK, Nielsen LS, et al
    Arterial Thromboembolism in Patients With Atrial Fibrillation and CHA(2)DS(2)-VASc 1: A Nationwide Study.
    Circulation. 2023 Dec 28. doi: 10.1161/CIRCULATIONAHA.123.066477.
    >> Share

  69. BERGEMAN AT, Lieve KVV, Kallas D, Bos JM, et al
    Flecainide Is Associated With a Lower Incidence of Arrhythmic Events in a Large Cohort of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia.
    Circulation. 2023;148:2029-2037.
    >> Share

  70. VAN DUIJVENBODEN S, Ramirez J, Orini M, Aung N, et al
    Prognostic Significance of Different Ventricular Ectopic Burdens During Submaximal Exercise in Asymptomatic UK Biobank Subjects.
    Circulation. 2023;148:1932-1944.
    >> Share

  71. KATAOKA N, Imamura T, Kinugawa K
    Letter by Kataoka et al Regarding Article, "Long-Term Outcomes of Brugada Substrate Ablation: A Report From BRAVO (Brugada Ablation of VF Substrate Ongoing Multicenter Registry)".
    Circulation. 2023;148:1914.
    >> Share

    November 2023
  72. JOGLAR JA, Chung MK, Armbruster AL, Benjamin EJ, et al
    2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2023 Nov 30. doi: 10.1161/CIR.0000000000001193.
    >> Share

  73. KHIDHIR A, Curtis AB
    Perspective on ACC/AHA/ACCP/HRS Guidelines for the Management of Atrial Fibrillation.
    Circulation. 2023 Nov 30. doi: 10.1161/CIRCULATIONAHA.123.066919.
    >> Share

  74. ROWIN EJ, Link MS, Maron MS, Maron BJ, et al
    Evolving Contemporary Management of Atrial Fibrillation in Hypertrophic Cardiomyopathy.
    Circulation. 2023;148:1797-1811.
    >> Share

  75. HIGUCHI S, Voskoboinik A, Il Im S, Lee A, et al
    Frequent Premature Atrial Contractions Lead to Adverse Atrial Remodeling and Atrial Fibrillation in a Swine Model.
    Circulation. 2023 Nov 23. doi: 10.1161/CIRCULATIONAHA.123.065874.
    >> Share

  76. GONZALEZ-TORRECILLA E, Luna Lopez R, Avila Alonso P
    Atrioventricular Block: Does This Patient Require a Pacemaker?
    Circulation. 2023;148:1725-1727.
    >> Share

  77. SEO K, Yamamoto Y, Kirillova A, Kawana M, et al
    Improved Cardiac Performance and Decreased Arrhythmia in Hypertrophic Cardiomyopathy With Non-beta-Blocking R-Enantiomer Carvedilol.
    Circulation. 2023;148:1691-1704.
    >> Share

  78. QI M, Ma S, Liu J, Liu X, et al
    In Vivo Base Editing of Scn5a Rescues Type 3 Long QT Syndrome in Mice.
    Circulation. 2023 Nov 15. doi: 10.1161/CIRCULATIONAHA.123.065624.
    >> Share

  79. WILDE AAM, Saenen J
    Risk Stratification in Brugada Syndrome: How Low Can We Go?
    Circulation. 2023;148:1556-1558.
    >> Share

  80. BELBACHIR N, Wu Y, Shen M, Zhang SL, et al
    Studying Long QT Syndrome Caused by NAA10 Genetic Variants Using Patient-Derived Induced Pluripotent Stem Cells.
    Circulation. 2023;148:1598-1601.
    >> Share

  81. KIM MC, Lim Y, Lee SH, Shin Y, et al
    Early Left Ventricular Unloading or Conventional Approach After Venoarterial Extracorporeal Membrane Oxygenation: The EARLY-UNLOAD Randomized Clinical Trial.
    Circulation. 2023;148:1570-1581.
    >> Share

  82. GAITA F, Cerrato N, Giustetto C, Martino A, et al
    Asymptomatic Patients With Brugada ECG Pattern: Long-Term Prognosis From a Large Prospective Study.
    Circulation. 2023;148:1543-1555.
    >> Share

  83. HOSOKAWA K, Watanabe H, Taniguchi Y, Ikeda N, et al
    A Multicenter, Single-Blind, Randomized, Warfarin-Controlled Trial of Edoxaban in Patients With Chronic Thromboembolic Pulmonary Hypertension: KABUKI Trial.
    Circulation. 2023 Nov 13. doi: 10.1161/CIRCULATIONAHA.123.067528.
    >> Share

  84. MCINTYRE WF, Benz AP, Becher N, Healey JS, et al
    Direct Oral Anticoagulants for Stroke Prevention in Patients with Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials.
    Circulation. 2023 Nov 12. doi: 10.1161/CIRCULATIONAHA.123.067512.
    >> Share

  85. POKORNEY SD, Granger CB
    The Need for Randomized Trials to Define the Optimal Dose of Anticoagulants for Atrial Fibrillation in Chronic Kidney Disease.
    Circulation. 2023;148:1455-1458.
    >> Share

    October 2023
  86. STEVENSON WG, Tandri H, Roden DM
    The Shape of Ventricular Tachycardia.
    Circulation. 2023;148:1368-1370.
    >> Share

  87. NISHIMURA T, Shatz N, Weiss JP, Zawaneh M, et al
    Identification of Human Ventricular Tachycardia Demarcated by Fixed Lines of Conduction Block in a 3-Dimensional Hyperboloid Circuit.
    Circulation. 2023;148:1354-1367.
    >> Share

  88. KAPADIA SR, Krishnaswamy A, Whisenant B, Potluri S, et al
    Concomitant Left Atrial Appendage Occlusion and Transcatheter Aortic Valve Replacement Among Patients with Atrial Fibrillation.
    Circulation. 2023 Oct 24. doi: 10.1161/CIRCULATIONAHA.123.067312.
    >> Share

  89. O'HARA PE, Venkatesh V, Lehrenbaum H
    A Unique Case of Right Axis Deviation.
    Circulation. 2023;148:1261-1262.
    >> Share

  90. KRISAI P, Kuhne M, Sticherling C
    Letter by Krisai et al Regarding Article, "Pulsed Field Ablation for the Treatment of Atrial Fibrillation: PULSED AF Pivotal Trial".
    Circulation. 2023;148:1182.
    >> Share

  91. BUTT JH, Yafasova A, Doi SN, Nielsen JC, et al
    Implantable Cardioverter Defibrillator in Patients With Nonischemic Systolic Heart Failure With and Without Cardiac Resynchronization Therapy: Extended Follow-Up Study of the DANISH Trial.
    Circulation. 2023;148:1179-1181.
    >> Share

    September 2023
  92. PARKASH R, O'Meara E, Tang ASL
    The Role of Ablation-Based Rhythm Control in the Tangled Web of Atrial Fibrillation and Heart Failure.
    Circulation. 2023;148:933-935.
    >> Share

  93. EZEKOWITZ MD, Kamareddine M
    Filling an Important Knowledge Gap: The DOAC Score.
    Circulation. 2023;148:947-949.
    >> Share

  94. PERERA D, Morgan HP, Ryan M, Dodd M, et al
    Arrhythmia and Death Following Percutaneous Revascularization in Ischemic Left Ventricular Dysfunction: Prespecified Analyses From the REVIVED-BCIS2 Trial.
    Circulation. 2023;148:862-871.
    >> Share

  95. XU Y, Chang AR, Inker LA, McAdams-DeMarco M, et al
    Associations of Apixaban Dose With Safety and Effectiveness Outcomes in Patients With Atrial Fibrillation and Severe Chronic Kidney Disease.
    Circulation. 2023 Sep 8. doi: 10.1161/CIRCULATIONAHA.123.065614.
    >> Share

  96. PUNDI K, Marcus GM, Turakhia M
    The Epidemic and Data-Free Zone of Nonsustained Ventricular Tachycardia: An Unintended Consequence of Digital Monitoring and a Path Forward.
    Circulation. 2023;148:805-807.
    >> Share

  97. XIAO SY, Goldschlager N, Durstenfeld MS
    Chest Pain, Bundle Branch Block, and Wide Complex Tachycardia: Is Three a Company or Crowd?
    Circulation. 2023;148:845-847.
    >> Share

    August 2023
  98. JOOSTEN LPT, van Doorn S, van de Ven PM, Kohlen BTG, et al
    Safety of Switching from a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients with Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial.
    Circulation. 2023 Aug 27. doi: 10.1161/CIRCULATIONAHA.123.066485.
    >> Share

  99. AGGARWAL R, Ruff CT, Virdone S, Perreault S, et al
    Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants.
    Circulation. 2023 Aug 25. doi: 10.1161/CIRCULATIONAHA.123.064556.
    >> Share

  100. MUSTROPH J, Baier MJ, Unsin D, Provaznik Z, et al
    Ethanol-Induced Atrial Fibrillation Results From Late I(Na) and Can Be Prevented by Ranolazine.
    Circulation. 2023;148:698-700.
    >> Share

  101. ALGALARRONDO V, Extramiana F
    Autoimmune Atrial Fibrillation or Atrial Fibrillation-Induced Autoimmunity? A New Atrial Fibrillation Begets Atrial Fibrillation Pathway?
    Circulation. 2023;148:499-501.
    >> Share

  102. JIAO T, Ruzieh M
    Letter by Jiao and Ruzieh Regarding Article, "Comparative Effectiveness of Left Atrial Appendage Occlusion Versus Oral Anticoagulation by Sex".
    Circulation. 2023;148:508-509.
    >> Share

  103. RAJJOUB K, Rajjoub EA, Ramos-Jimenez J
    What Is the Mechanism of the Premature Beats?
    Circulation. 2023;148:426-429.
    >> Share

    July 2023
  104. VAZQUEZ E, Vazquez-Sanchez T, Sanchez-Perales C
    Letter by Vazquez et al Regarding Article, "Apixaban for Patients With Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial".
    Circulation. 2023;148:378.
    >> Share

  105. YOUNIS A, Ali S, Hsich E, Goldenberg I, et al
    Arrhythmia and Survival Outcomes Among Black Patients and White Patients With a Primary Prevention Defibrillator.
    Circulation. 2023;148:241-252.
    >> Share

  106. AL-KHATIB SM, Thomas KL
    Advancing Equity in Sudden Cardiac Death Prevention: Beware of Making Assumptions About the Effectiveness of Primary Prevention Implantable Cardioverter-Defibrillators in Black Patients.
    Circulation. 2023;148:253-255.
    >> Share

  107. HAISSAGUERRE M, Duchateau J, Laredo M, Lavergne T, et al
    Inducibility of Short-Coupled Purkinje Ectopy by Pharmacological Tests in Patients With Spontaneous Short-Coupled Idiopathic Ventricular Fibrillation.
    Circulation. 2023;148:70-72.
    >> Share

  108. MAGUY A, Mahendran Y, Tardif JC, Busseuil D, et al
    Autoimmune Atrial Fibrillation.
    Circulation. 2023 Jul 4. doi: 10.1161/CIRCULATIONAHA.122.062776.
    >> Share

    June 2023
  109. HOCHSTADT A, Geist M, Viskin S
    Occam's Razor: Two Arrhythmias in a Single Heart?
    Circulation. 2023;147:1779-1781.
    >> Share

  110. COULT J, Yang BY, Kwok H, Kutz JN, et al
    Prediction of Shock-Refractory Ventricular Fibrillation During Resuscitation of Out-of-Hospital Cardiac Arrest.
    Circulation. 2023 Jun 2. doi: 10.1161/CIRCULATIONAHA.122.063651.
    >> Share

    May 2023
  111. DOUNDOULAKIS I, Tsioufis K, Gatzoulis KA
    Letter by Doundoulakis et al Regarding Article, "Programmed Ventricular Stimulation as Additional Primary Prevention Risk Stratification Tool in Arrhythmogenic Right Ventricular Cardiomyopathy".
    Circulation. 2023;147:1714.
    >> Share

  112. MILES C, Boukens BJ, Scrocco C, Wilde AAM, et al
    Subepicardial Cardiomyopathy: A Disease Underlying J-Wave Syndromes and Idiopathic Ventricular Fibrillation.
    Circulation. 2023;147:1622-1633.
    >> Share

  113. VISKIN S, Rosso R
    Treatment of Brugada Syndrome in 2023: Know Where You Come From to Know Where You Are Going.
    Circulation. 2023;147:1579-1581.
    >> Share

  114. NADEMANEE K, Chung FP, Sacher F, Nogami A, et al
    Long-Term Outcomes of Brugada Substrate Ablation: A Report from BRAVO (Brugada Ablation of VF Substrate Ongoing Multicenter Registry).
    Circulation. 2023;147:1568-1578.
    >> Share

  115. TURAGAM MK, Neuzil P, Schmidt B, Reichlin T, et al
    Safety and Effectiveness of Pulsed Field Ablation to Treat Atrial Fibrillation: One-Year Outcomes From the MANIFEST-PF Registry.
    Circulation. 2023 May 18. doi: 10.1161/CIRCULATIONAHA.123.064959.
    >> Share

  116. RUSSO AM
    Pulsed Field Ablation: Is It Better Than Conventional Thermal Ablation for Treatment of Atrial Fibrillation?
    Circulation. 2023;147:1433-1435.
    >> Share

  117. GUPTA AR, Deshmukh AJ, Del-Carpio Munoz F
    A Tale of Two Parallel Rhythms.
    Circulation. 2023;147:1463-1466.
    >> Share

  118. DUAN H, Zhang CH
    A Series of Abnormal ECGs: Are They Benign or Sinister?
    Circulation. 2023;147:1407-1410.
    >> Share

  119. WANG Y, Wang J, Shi L, Chen X, et al
    CIB2 Is a Novel Endogenous Repressor of Atrial Remodeling.
    Circulation. 2023 May 2. doi: 10.1161/CIRCULATIONAHA.122.062660.
    >> Share

    April 2023

  120. Correction to: Atrial Fibrillation Occurring During Acute Hospitalization: A Scientific Statement From the American Heart Association.
    Circulation. 2023;147:e717.
    >> Share

  121. XING LY, Diederichsen SZ, Hojberg S, Krieger DW, et al
    Effects of Systematic Atrial Fibrillation Screening According to N-Terminal Pro-B-Type Natriuretic Peptide: a Secondary Analysis of the Randomized LOOP Study.
    Circulation. 2023 Apr 15. doi: 10.1161/CIRCULATIONAHA.123.064361.
    >> Share

  122. HARRINGTON J, Carnicelli AP, Hua K, Wallentin L, et al
    Direct Oral Anticoagulants Versus Warfarin Across the Spectrum of Kidney Function: Patient-Level Network Meta-Analyses From COMBINE AF.
    Circulation. 2023 Apr 12. doi: 10.1161/CIRCULATIONAHA.122.062752.
    >> Share

  123. KIM JU, Bray J, Ahmad M
    Letter by Kim et al Regarding Article, "Detection of Atrial Fibrillation in a Large Population Using Wearable Devices: The Fitbit Heart Study".
    Circulation. 2023;147:1186-1187.
    >> Share

    March 2023
  124. BAPAT A, Schloss MJ, Yamazoe M, Grune J, et al
    A Mouse Model of Atrial Fibrillation in Sepsis.
    Circulation. 2023;147:1047-1049.
    >> Share

  125. CHYOU JY, Barkoudah E, Dukes JW, Goldstein LB, et al
    Atrial Fibrillation Occurring During Acute Hospitalization: A Scientific Statement From the American Heart Association.
    Circulation. 2023 Mar 13. doi: 10.1161/CIR.0000000000001133.
    >> Share

  126. HYDES TJ, Lip GYH, Lane DA
    Use of Direct-Acting Oral Anticoagulants in Patients With Atrial Fibrillation and Chronic Liver Disease.
    Circulation. 2023;147:795-797.
    >> Share

  127. FRIEDMAN DJ, Al-Khatib SM, Dalgaard F, Fudim M, et al
    Cardiac Resynchronization Therapy Improves Outcomes in Patients With Intraventricular Conduction Delay But Not Right Bundle Branch Block: A Patient-Level Meta-Analysis of Randomized Controlled Trials.
    Circulation. 2023;147:812-823.
    >> Share

  128. VERMA A, Haines DE, Boersma LV, Sood N, et al
    Pulsed Field Ablation for the Treatment of Atrial Fibrillation: PULSED AF Pivotal Trial.
    Circulation. 2023 Mar 6. doi: 10.1161/CIRCULATIONAHA.123.063988.
    >> Share

    February 2023
  129. CONWAY J, Min S, Villa C, Weintraub RG, et al
    The Prevalence and Association of Exercise Test Abnormalities With Sudden Cardiac Death and Transplant-Free Survival in Childhood Hypertrophic Cardiomyopathy.
    Circulation. 2023;147:718-727.
    >> Share

  130. ZEITLER EP, Kearing S, Coylewright M, Nair D, et al
    Comparative Effectiveness of Left Atrial Appendage Occlusion Versus Oral Anticoagulation by Sex.
    Circulation. 2023;147:586-596.
    >> Share

  131. LAWAL OD, Aronow HD, Shobayo F, Hume AL, et al
    Comparative Effectiveness and Safety of Direct Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation and Chronic Liver Disease: A Nationwide Cohort Study.
    Circulation. 2023 Feb 10. doi: 10.1161/CIRCULATIONAHA.122.060687.
    >> Share

    January 2023
  132. HIGASHIKUNI Y, Liu W, Numata G, Tanaka K, et al
    NLRP3 Inflammasome Activation Through Heart-Brain Interaction Initiates Cardiac Inflammation and Hypertrophy During Pressure Overload.
    Circulation. 2023;147:338-355.
    >> Share

  133. HAGHIGHAT L, Goldschlager N, Oesterle A
    ECG Challenge: AV Block or Something Else?
    Circulation. 2023;147:267-270.
    >> Share

  134. YANG Z, Zhang CH, Li X
    What Is the Truth Behind Abnormal ECG Changes?
    Circulation. 2023;147:175-177.
    >> Share

    December 2022
  135. WEITZ JI, Eikelboom JW
    What Is the Future of Factor XI Inhibitors?
    Circulation. 2022;146:1899-1902.
    >> Share

  136. SHELBAYA K, Claggett B, Dorbala P, Skali H, et al
    Stages of Valvular Heart Disease Among Older Adults in the Community: The Atherosclerosis Risk in Communities Study.
    Circulation. 2022 Dec 16. doi: 10.1161/CIRCULATIONAHA.122.061396.
    >> Share

  137. BERSELL KR, Yang T, Mosley JD, Glazer AM, et al
    Transcriptional Dysregulation Underlies Both Monogenic Arrhythmia Syndrome and Common Modifiers of Cardiac Repolarization.
    Circulation. 2022 Dec 16. doi: 10.1161/CIRCULATIONAHA.122.062193.
    >> Share

  138. MARK ESTES NA, Jain S, Saba S
    Coronary Vasospasm With Pulse Field Ablation: Primum Non Nocere.
    Circulation. 2022;146:1820-1822.
    >> Share

  139. MARCUS GM
    Smartwatch-Detected Atrial Fibrillation: The "Value" in the Positive Predictive Value.
    Circulation. 2022;146:1733-1734.
    >> Share

  140. BENZ AP, Eikelboom JW
    Apixaban Compared With Warfarin in Patients With Atrial Fibrillation and End-Stage Renal Disease: Lessons Learned.
    Circulation. 2022;146:1746-1748.
    >> Share

  141. THIAGARAJAN N, Ho WHH, Lim DYZ, Loo WTW, et al
    Yield of Cardiac Magnetic Resonance Imaging in a Preparticipation Cohort of Young Asian Males With T Wave Inversion.
    Circulation. 2022;146:1802-1804.
    >> Share

    November 2022
  142. PRASAD P, Howell S, Sanghai S, Stecker E, et al
    Targeted Screening for Transthyretin Amyloid Cardiomyopathy in Patients With Atrial Fibrillation.
    Circulation. 2022;146:1730-1732.
    >> Share

  143. VALDERRABANO M, Fuentes Rojas SC, Lador A, Patel A, et al
    Substrate Ablation by Multivein, Multiballoon Coronary Venous Ethanol for Refractory Ventricular Tachycardia in Structural Heart Disease.
    Circulation. 2022;146:1644-1656.
    >> Share

  144. PRYSTOWSKY EN
    Rate Versus Rhythm Control for Atrial Fibrillation: Has the Debate Been Settled?
    Circulation. 2022;146:1561-1563.
    >> Share

  145. SCHINNER C, Xu L, Franz H, Zimmermann A, et al
    Defective Desmosomal Adhesion Causes Arrhythmogenic Cardiomyopathy by Involving an Integrin-alphaVbeta6/TGF-beta Signaling Cascade.
    Circulation. 2022;146:1610-1626.
    >> Share

  146. ZHANG S, Liu S, Leach JP, Li K, et al
    Gene Therapy Knockdown of Hippo Signaling Resolves Arrhythmic Events in Pigs After Myocardial Infarction.
    Circulation. 2022;146:1558-1560.
    >> Share

  147. BRANDES A, Stavrakis S, Freedman B, Antoniou S, et al
    Consumer-Led Screening for Atrial Fibrillation: Frontier Review of the AF-SCREEN International Collaboration.
    Circulation. 2022;146:1461-1474.
    >> Share

  148. HAN J, Husband G, Doppalapudi H
    Tachycardia Associated With Pacing.
    Circulation. 2022;146:1475-1477.
    >> Share

  149. KANAOKA K, Onoue K, Terasaki S, Nakano T, et al
    Features and Outcomes of Histologically Proven Myocarditis With Fulminant Presentation.
    Circulation. 2022;146:1425-1433.
    >> Share


  150. Correction to: Early Versus Delayed Non-Vitamin K Antagonist Oral Anticoagulant Therapy After Acute Ischemic Stroke in Atrial Fibrillation (TIMING): A Registry-Based Randomized Controlled Noninferiority Study.
    Circulation. 2022;146:e279.
    >> Share

  151. POKORNEY SD, Chertow GM, Al-Khalidi HR, Gallup D, et al
    Apixaban for Patients with Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial.
    Circulation. 2022 Nov 6. doi: 10.1161/CIRCULATIONAHA.121.054990.
    >> Share

  152. REINECKE H, Engelbertz C, Bauersachs R, Breithardt G, et al
    A Randomized Controlled Trial Comparing Apixaban to the Vitamin K-antagonist Phenprocoumon in Patients on Chronic Hemodialysis: The AXADIA-AFNET 8 study.
    Circulation. 2022 Nov 6. doi: 10.1161/CIRCULATIONAHA.122.062779.
    >> Share

    October 2022
  153. VISKIN S, Chorin E, Schwartz AL, Kukla P, et al
    Arrhythmogenic Effects of Cardiac Memory.
    Circulation. 2022;146:1170-1181.
    >> Share

  154. GASPERETTI A, Carrick RT, Costa S, Compagnucci P, et al
    Programmed Ventricular Stimulation as an Additional Primary Prevention Risk Stratification Tool in Arrhythmogenic Right Ventricular Cardiomyopathy: A Multinational Study.
    Circulation. 2022 Oct 7:101161CIRCULATIONAHA122060866.
    >> Share

    September 2022
  155. PATTEN RD, Shah SP
    Addressing the Risk of Ventricular Arrhythmias and Sudden Death in Patients With Cardiac Sarcoidosis.
    Circulation. 2022;146:976-979.
    >> Share


  156. Correction to: Association of Blood Pressure Classification Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline With Risk of Heart Failure and Atrial Fibrillation.
    Circulation. 2022;146:e186.
    >> Share

  157. LUBITZ SA, Faranesh AZ, Selvaggi C, Atlas SJ, et al
    Detection of Atrial Fibrillation in a Large Population Using Wearable Devices: The Fitbit Heart Study.
    Circulation. 2022 Sep 23:101161CIRCULATIONAHA122060291.
    >> Share

  158. REDDY VY, Petru J, Funasako M, Kopriva K, et al
    Coronary Arterial Spasm During Pulsed Field Ablation to Treat Atrial Fibrillation.
    Circulation. 2022 Sep 22:101161CIRCULATIONAHA122061497.
    >> Share

  159. AL-KHATIB SM, Wojdyla DM, Granger CB, Wallentin L, et al
    Duration of Anticoagulation Interruption Before Invasive Procedures and Outcomes in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial.
    Circulation. 2022;146:958-960.
    >> Share

  160. TSAI CF, Chuang YT, Chang KW
    A Peculiar Wide Complex Tachycardia During Flecainide Treatment.
    Circulation. 2022;146:955-957.
    >> Share

  161. YANG E, Calkins H
    Who Benefits Most From Early Rhythm Control in Newly Diagnosed Atrial Fibrillation?
    Circulation. 2022;146:848-850.
    >> Share

  162. OLDGREN J, Asberg S, Hijazi Z, Wester P, et al
    Early Versus Delayed Non-Vitamin K Antagonist Oral Anticoagulant Therapy After Acute Ischemic Stroke in Atrial Fibrillation (TIMING): A Registry-Based Randomized Controlled Noninferiority Study.
    Circulation. 2022 Sep 6:101161CIRCULATIONAHA122060666.
    >> Share

    August 2022
  163. MEHRA R, Chung MK, Olshansky B, Dobrev D, et al
    Sleep-Disordered Breathing and Cardiac Arrhythmias in Adults: Mechanistic Insights and Clinical Implications: A Scientific Statement From the American Heart Association.
    Circulation. 2022;146:e119-e136.
    >> Share

  164. ZHAO Y, Riching AS, Knight WE, Chi C, et al
    Cardiomyocyte-Specific Long Noncoding RNA Regulates Alternative Splicing of the Triadin Gene in the Heart.
    Circulation. 2022;146:699-714.
    >> Share

  165. NORDENSWAN HK, Poyhonen P, Lehtonen J, Ekstrom K, et al
    Incidence of Sudden Cardiac Death and Life-Threatening Arrhythmias in Clinically Manifest Cardiac Sarcoidosis With and Without Current Indications for an Implantable Cardioverter Defibrillator.
    Circulation. 2022 Aug 24:101161CIRCULATIONAHA121058120.
    >> Share

  166. RADINOVIC A, Della Bella P
    Response by Radinovic and Della Bella to Letter Regarding Article, "Does Timing of Ventricular Tachycardia Ablation Affect Prognosis in Patients With an Implantable Cardioverter Defibrillator? Results From the Multicenter Randomized PARTITA Trial".
    Circulation. 2022;146:e71-e72.
    >> Share

  167. BENALI K, Guenancia C, Martins RP
    Letter by Benali et al Regarding Article, "Does Timing of Ventricular Tachycardia Ablation Affect Prognosis in Patients With an Implantable Cardioverter Defibrillator? Results From the Multicenter Randomized PARTITA Trial".
    Circulation. 2022;146:e69-e70.
    >> Share

  168. RILLIG A, Borof K, Breithardt G, Camm AJ, et al
    Early Rhythm Control in Patients With Atrial Fibrillation and High Comorbidity Burden.
    Circulation. 2022 Aug 15:101161CIRCULATIONAHA122060274.
    >> Share

    July 2022
  169. VAN DER STUIJT W, Smeding L, Olde Nordkamp LRA, Knops RE, et al
    Response by van der Stuijt et al to Letter Regarding Article, "Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: Analysis of All Appropriate Therapy in the PRAETORIAN Trial
    Circulation. 2022;146:e10-e11.
    >> Share

  170. MADIAS C, Madias JE
    Letter by Madias and Madias Regarding Article, "Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: Analysis of All Appropriate Therapy in the PRAETORIAN Trial".
    Circulation. 2022;146:e8-e9.
    >> Share

  171. REDDY YNV, Borlaug BA, Gersh BJ
    Management of Atrial Fibrillation Across the Spectrum of Heart Failure With Preserved and Reduced Ejection Fraction.
    Circulation. 2022;146:339-357.
    >> Share

  172. ESSIEN UR, Johnson AE
    Whose Streets? Neighborhood-Level Determinants of Atrial Fibrillation Care.
    Circulation. 2022;146:172-174.
    >> Share

  173. SHAH RA, Asatryan B, Sharaf Dabbagh G, Aung N, et al
    Frequency, Penetrance, and Variable Expressivity of Dilated Cardiomyopathy-Associated Putative Pathogenic Gene Variants in UK Biobank Participants.
    Circulation. 2022;146:110-124.
    >> Share

  174. TONG D, Schiattarella GG, Jiang N, Daou D, et al
    Impaired AMP-Activated Protein Kinase Signaling in Heart Failure With Preserved Ejection Fraction-Associated Atrial Fibrillation.
    Circulation. 2022;146:73-76.
    >> Share

    June 2022
  175. AVENDANO R, Lavi N, Rosenfeld LE
    Around and Around...A Wide Complex Tachycardia.
    Circulation. 2022;145:1867-1869.
    >> Share

  176. KANAGASUNDRAM AN, Richardson TD, Stevenson WG
    Can Early Ablation of Ventricular Tachycardia Improve Survival?
    Circulation. 2022;145:1850-1852.
    >> Share

  177. TUNG R, Xue Y, Chen M, Jiang C, et al
    First-Line Catheter Ablation of Monomorphic Ventricular Tachycardia in Cardiomyopathy Concurrent With Defibrillator Implantation: The PAUSE-SCD Randomized Trial.
    Circulation. 2022;145:1839-1849.
    >> Share

  178. CHEW DS, Li Y, Cowper PA, Anstrom KJ, et al
    Cost-Effectiveness of Catheter Ablation Versus Antiarrhythmic Drug Therapy in Atrial Fibrillation: The CABANA Randomized Clinical Trial.
    Circulation. 2022 Jun 21:101161CIRCULATIONAHA122058575.
    >> Share

  179. MORGAN E, Anderson J, Noheria A
    Premature Complexes and Blocked P Wave.
    Circulation. 2022;145:1803-1805.
    >> Share

  180. ABDEL-QADIR H, Akioyamen LE, Fang J, Pang A, et al
    Association of Neighborhood-Level Material Deprivation With Atrial Fibrillation Care in a Single-Payer Health Care System: A Population-Based Cohort Study.
    Circulation. 2022 Jun 9:101161CIRCULATIONAHA122058949.
    >> Share

  181. POKORNEY SD, Granger CB
    Evidence Builds for Catheter Ablation for Atrial Fibrillation and Heart Failure.
    Circulation. 2022;145:1705-1707.
    >> Share

    May 2022
  182. MAQSOOD N, Cooper JM, Whitman IR
    Letter by Maqsood et al Regarding Article, "Anterior-Lateral Versus Anterior-Posterior Electrode Position for Cardioverting Atrial Fibrillation".
    Circulation. 2022;145:e1054-e1055.
    >> Share

  183. IBRAHIM OA, Belley-Cote EP, McIntyre WF
    Letter by Ibrahim et al Regarding Article, "Anterior-Lateral Versus Anterior-Posterior Electrode Position for Cardioverting Atrial Fibrillation".
    Circulation. 2022;145:e1056.
    >> Share

  184. SCHMIDT AS, Lauridsen KG, Albertsen AE, Lofgren B, et al
    Response to Letters Regarding Article, "Anterior-Lateral Versus Anterior-Posterior Electrode Position for Cardioverting Atrial Fibrillation".
    Circulation. 2022;145:e1057-e1058.
    >> Share

  185. NAUFFAL V, Morrill VN, Jurgens SJ, Choi SH, et al
    Monogenic and Polygenic Contributions to QTc Prolongation in the Population.
    Circulation. 2022;145:1524-1533.
    >> Share

  186. VAN OPBERGEN CJM, Bagwan N, Maurya SR, Kim JC, et al
    Exercise Causes Arrhythmogenic Remodeling of Intracellular Calcium Dynamics in Plakophilin-2-Deficient Hearts.
    Circulation. 2022;145:1480-1496.
    >> Share

  187. GROENEVELD SA, van der Ree MH, Mulder BA, Balt J, et al
    Prevalence of Short-Coupled Ventricular Fibrillation in a Large Cohort of Dutch Patients With Idiopathic Ventricular Fibrillation.
    Circulation. 2022;145:1437-1439.
    >> Share

    April 2022
  188. NATALE A, Kar S, Holmes D
    Letter by Natale et al Regarding Article, "Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial".
    Circulation. 2022;145:e847-e848.
    >> Share

  189. PRICE MJ, Gibson DN, Kar S
    Letter by Price et al Regarding the Article, "Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial".
    Circulation. 2022;145:e849.
    >> Share

  190. DHRUVA SS, Redberg RF
    Letter by Dhruva and Redberg Regarding Article, "Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial".
    Circulation. 2022;145:e845-e846.
    >> Share

  191. HOCHSTADT A, Rosso R, Viskin S
    Sinus Node Dysfunction With a Nice Twist.
    Circulation. 2022;145:1285-1287.
    >> Share


  192. Correction to: Atrial Fibrillation and Dementia: A Report From the AF-SCREEN International Collaboration.
    Circulation. 2022;145:e842.
    >> Share

  193. FATKIN D, Cox CD, Martinac B
    Fishing for Links Between Omega-3 Fatty Acids and Atrial Fibrillation.
    Circulation. 2022;145:1037-1039.
    >> Share

  194. DELLA BELLA P, Baratto F, Vergara P, Bertocchi P, et al
    Does Timing of Ventricular Tachycardia Ablation Affect Prognosis in Patients With an Implantable Cardioverter Defibrillator? Results From the Multicenter Randomized PARTITA Trial.
    Circulation. 2022 Apr 3. doi: 10.1161/CIRCULATIONAHA.122.059598.
    >> Share

    March 2022
  195. EXTRAMIANA F, Steg PG
    Atrial Fibrillation Screening: The Tools Are Ready, But Should We Do It?
    Circulation. 2022;145:955-958.
    >> Share

  196. MUGNAI G, Gambaro A, Ribichini FL
    A Tachycardia in Disguise.
    Circulation. 2022;145:1024-1028.
    >> Share

  197. PARKASH R, Wells GA, Rouleau J, Talajic M, et al
    Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients with Heart Failure and Atrial Fibrillation: Results from the RAFT-AF trial.
    Circulation. 2022 Mar 22. doi: 10.1161/CIRCULATIONAHA.121.057095.
    >> Share

  198. WALSH R, Bezzina C, Wilde AAM
    First Steps of Population Genomic Medicine in the Arrhythmia World: Pros and Cons.
    Circulation. 2022;145:892-895.
    >> Share

  199. GLAZER AM, Davogustto G, Shaffer CM, Vanoye CG, et al
    Arrhythmia Variant Associations and Reclassifications in the eMERGE-III Sequencing Study.
    Circulation. 2022;145:877-891.
    >> Share

  200. ANDRADE JG, Macle L
    Atrial Fibrillation Ablation: Aiming to Improve Quantity and Quality of Life.
    Circulation. 2022;145:805-807.
    >> Share

  201. TANG Y, Zhang Y, Yang XY
    Rare Case of Wide QRS Tachycardia After Sintilimab Treatment for Lung Cancer.
    Circulation. 2022;145:783-786.
    >> Share

  202. KOWALEWSKI C, Dagres N, Hindricks G
    Are 2 Left Atrial Appendage Guards Better Than 1? The Amulet IDE Randomized Trial.
    Circulation. 2022;145:739-741.
    >> Share

  203. BOAS R, Sappler N, von Stulpnagel L, Klemm M, et al
    Periodic Repolarization Dynamics Identifies ICD Responders in Nonischemic Cardiomyopathy: A DANISH Substudy.
    Circulation. 2022;145:754-764.
    >> Share

  204. GALEA R, De Marco F, Meneveau N, Aminian A, et al
    Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinical Trial.
    Circulation. 2022;145:724-738.
    >> Share

  205. LUBITZ SA, Atlas SJ, Ashburner JM, Trisini Lipsanopoulos AT, et al
    Screening for Atrial Fibrillation in Older Adults at Primary Care Visits: the VITAL-AF Randomized Controlled Trial.
    Circulation. 2022 Mar 2. doi: 10.1161/CIRCULATIONAHA.121.057014.
    >> Share

  206. YOSHIDA T, Nakamura A, Funada J, Amino M, et al
    Efficacy and Safety of Edoxaban 15 mg According to Renal Function in Very Elderly Patients With Atrial Fibrillation: A Subanalysis of the ELDERCARE-AF Trial.
    Circulation. 2022;145:718-720.
    >> Share

    February 2022

  207. Correction to: Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex.
    Circulation. 2022;145:e640.
    >> Share

  208. VAN OUWERKERK AF, Bosada FM, van Duijvenboden K, Houweling AC, et al
    Patient-Specific TBX5-G125R Variant Induces Profound Transcriptional Deregulation and Atrial Dysfunction.
    Circulation. 2022;145:606-619.
    >> Share

  209. HAUSLER KG, Eichner FA, Heuschmann PU, Fiebach JB, et al
    MRI-Detected Brain Lesions and Cognitive Function in Atrial Fibrillation Patients Undergoing Left Atrial Catheter Ablation in the Randomized AXAFA-AFNET 5 Trial.
    Circulation. 2022 Feb 9. doi: 10.1161/CIRCULATIONAHA.121.056320.
    >> Share

  210. RIVARD L, Friberg L, Conen D, Healey JS, et al
    Atrial Fibrillation and Dementia: A Report From the AF-SCREEN International Collaboration.
    Circulation. 2022;145:392-409.
    >> Share

  211. PELTENBURG PJ, Kallas D, Bos JM, Lieve KVV, et al
    An International Multicenter Cohort Study on beta-Blockers for the Treatment of Symptomatic Children With Catecholaminergic Polymorphic Ventricular Tachycardia.
    Circulation. 2022;145:333-344.
    >> Share

  212. KNOPS RE, van der Stuijt W, Delnoy PPHM, Boersma LVA, et al
    Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: Analysis of All Appropriate Therapy in the PRAETORIAN Trial.
    Circulation. 2022;145:321-329.
    >> Share

    January 2022
  213. GOTO S, Goto S
    A Patient-Level Meta-Analysis: The End of the Era of Direct Oral Anticoagulant Developmental Trials in Patients With Atrial Fibrillation?
    Circulation. 2022;145:256-258.
    >> Share

  214. WADA Y, Yang T, Shaffer CM, Daniel LL, et al
    Common Ancestry-Specific Ion Channel Variants Predispose to Drug-Induced Arrhythmias.
    Circulation. 2022;145:299-308.
    >> Share

  215. CARNICELLI AP, Hong H, Connolly SJ, Eikelboom J, et al
    Direct Oral Anticoagulants versus Warfarin in Patients with Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials with Interaction Testing by Age and Sex.
    Circulation. 2022 Jan 5. doi: 10.1161/CIRCULATIONAHA.121.056355.
    >> Share

    December 2021
  216. BAHNSON TD, Giczewska A, Mark DB, Russo AM, et al
    Association Between Age and Outcomes of Catheter Ablation Versus Medical Therapy for Atrial Fibrillation: Results from the CABANA Trial.
    Circulation. 2021 Dec 22. doi: 10.1161/CIRCULATIONAHA.121.055297.
    >> Share

  217. SAMUEL M, Nattel S
    Fish Oil Supplements May Increase the Risk for Atrial Fibrillation: What Does This Mean?
    Circulation. 2021;144:1991-1994.
    >> Share

  218. MIRANDA-ARBOLEDA AF, Mohammad S, Baranchuk A
    Wide Complex Tachycardia and Syncope in the Emergency Department.
    Circulation. 2021;144:2040-2042.
    >> Share

  219. STEINBERG C, Dognin N, Sodhi A, Champagne C, et al
    Driving Restrictions and Early Arrhythmias in Patients Receiving a Secondary Prevention Implantable Cardioverter-Defibrillator (DREAM-ICD-II study).
    Circulation. 2021 Dec 16. doi: 10.1161/CIRCULATIONAHA.121.056471.
    >> Share

  220. WARD-CAVINESS CK
    Accelerated Epigenetic Aging and Incident Atrial Fibrillation: New Outlook on an Immutable Risk Factor?
    Circulation. 2021;144:1912-1914.
    >> Share

    November 2021
  221. HANKEY GJ
    Embolic Stroke of Undetermined Source: Can We Identify Subgroups With High Risk for Atrial Fibrillation Who May Benefit From Oral Anticoagulation?
    Circulation. 2021;144:1747-1749.
    >> Share

  222. FINOCCHIARO G, Westaby J, Bhatia R, Malhotra A, et al
    Sudden Death in Female Athletes: Insights From a Large Regional Registry in the United Kingdom.
    Circulation. 2021;144:1827-1829.
    >> Share

  223. SASMITA BR, Luo S, Huang B
    Wide and Narrow QRS Complex Tachycardia With Cycle Length Alternans: What Is the Mechanism?
    Circulation. 2021;144:1824-1826.
    >> Share

  224. AGUILAR M, Macle L, Deyell MW, Yao R, et al
    The Influence of Monitoring Strategy on Assessment of Ablation Success and Post-ablation Atrial Fibrillation Burden Assessment: Implications for Practice and Clinical Trial Design.
    Circulation. 2021 Nov 24. doi: 10.1161/CIRCULATIONAHA.121.056109.
    >> Share

  225. SCHMIDT AS, Lauridsen KG, Moller DS, Christensen PD, et al
    Anterior-Lateral Versus Anterior-Posterior Electrode Position for Cardioverting Atrial Fibrillation.
    Circulation. 2021 Nov 24. doi: 10.1161/CIRCULATIONAHA.121.056301.
    >> Share

  226. BERTERO E, Nickel A, Kohlhaas M, Hohl M, et al
    Loss of Mitochondrial Ca(2+) Uniporter Limits Inotropic Reserve and Provides Trigger and Substrate for Arrhythmias in Barth Syndrome Cardiomyopathy.
    Circulation. 2021;144:1694-1713.
    >> Share

  227. KIRCHHOF P
    In Patients With Recently Diagnosed Atrial Fibrillation, Think Anticoagulation and Rhythm Control.
    Circulation. 2021;144:1587-1589.
    >> Share

  228. KHURSHID S, Friedman S, Reeder C, Di Achille P, et al
    Electrocardiogram-based Deep Learning and Clinical Risk Factors to Predict Atrial Fibrillation.
    Circulation. 2021 Nov 8. doi: 10.1161/CIRCULATIONAHA.121.057480.
    >> Share

  229. ROMANI F, Monasky MM, Pappone C
    Letter by Romani et al Regarding Article, "Extracellular Vesicles From Epicardial Fat Facilitate Atrial Fibrillation".
    Circulation. 2021;144:e280-e281.
    >> Share

  230. LEOR J, Ram E, Naftali-Shani N, Shaihov-Teper O, et al
    Response by Leor et al to Letter Regarding Article, "Extracellular Vesicles From Epicardial Fat Facilitate Atrial Fibrillation".
    Circulation. 2021;144:e282.
    >> Share

    October 2021
  231. YAZAKI Y, Nakamura M, Iijima R, Yasuda S, et al
    Clinical Outcomes of Rivaroxaban Monotherapy in Heart Failure Patients With Atrial Fibrillation and Stable Coronary Disease: Insights From the AFIRE Trial.
    Circulation. 2021;144:1449-1451.
    >> Share

  232. BELHASSEN B, Shauer A, Biton Y
    Left Bundle-Branch Block Tachycardia After Transcatheter Aortic Valve Replacement.
    Circulation. 2021;144:1444-1448.
    >> Share

  233. BAHIT MC, Sacco RL, Easton JD, Meyerhoff J, et al
    Predictors of Development of Atrial Fibrillation in Patients With Embolic Stroke Of Undetermined Source: An Analysis of the RE-SPECT ESUS Trial.
    Circulation. 2021 Oct 15. doi: 10.1161/CIRCULATIONAHA.121.055176.
    >> Share

  234. HIGUCHI S, Goldschlager N, Gerstenfeld EP
    Atrioventricular Block With Narrow and Wide QRS: The Pause That Refreshes.
    Circulation. 2021;144:1262-1264.
    >> Share

  235. GENCER B, Djousse L, Al-Ramady OT, Cook NR, et al
    Effect of Long-Term Marine Omega-3 Fatty Acids Supplementation on the Risk of Atrial Fibrillation in Randomized Controlled Trials of Cardiovascular Outcomes: A Systematic Review and Meta-Analysis.
    Circulation. 2021 Oct 6. doi: 10.1161/CIRCULATIONAHA.121.055654.
    >> Share

    September 2021
  236. ROBERTS JD, Vittinghoff E, Lu AT, Alonso A, et al
    Epigenetic Age and the Risk of Incident Atrial Fibrillation.
    Circulation. 2021 Sep 30. doi: 10.1161/CIRCULATIONAHA.121.056456.
    >> Share

  237. HULSURKAR MM, Lahiri SK, Moore O, Moreira LM, et al
    Atrial-Specific LKB1 Knockdown Represents a Novel Mouse Model of Atrial Cardiomyopathy With Spontaneous Atrial Fibrillation.
    Circulation. 2021;144:909-912.
    >> Share

  238. VISKIN S, Chorin E, Viskin D, Hochstadt A, et al
    Polymorphic Ventricular Tachycardia: Terminology, Mechanism, Diagnosis, and Emergency Therapy.
    Circulation. 2021;144:823-839.
    >> Share

  239. SUN Z, Wang L, Han L, Wang Y, et al
    Functional Calsequestrin-1 Is Expressed in the Heart and Its Deficiency Is Causally Related to Malignant Hyperthermia-Like Arrhythmia.
    Circulation. 2021;144:788-804.
    >> Share

    August 2021
  240. MACHEREY S, Sinning JM, Mauri V
    Wide QRS Complex Bradycardia in a Hemodynamically Unstable Young Woman.
    Circulation. 2021;144:659-661.
    >> Share

  241. AN ZY, Peng D, Shi YJ
    A Patient With Acute Shortness of Breath and Inferior ST-Segment Elevation: A Diagnostic Trap.
    Circulation. 2021;144:577-579.
    >> Share

  242. RAAD N, Bittihn P, Cacheux M, Jeong D, et al
    Arrhythmia Mechanism and Dynamics in a Humanized Mouse Model of Inherited Cardiomyopathy Caused by Phospholamban R14del Mutation.
    Circulation. 2021;144:441-454.
    >> Share

  243. CHEANG S, LeLorier P, Gajewski K
    Diffuse ST-Segment Elevation With Idiopathic Malignant Ventricular Arrhythmia.
    Circulation. 2021;144:399-402.
    >> Share

    July 2021
  244. RILLIG A, Magnussen C, Ozga AK, Suling A, et al
    Early Rhythm Control Therapy in Patients with Atrial Fibrillation and Heart Failure.
    Circulation. 2021 Jul 30. doi: 10.1161/CIRCULATIONAHA.121.056323.
    >> Share

  245. REAL C, Morales T, Viana-Tejedor A
    An Unusual Call From the Urology Ward.
    Circulation. 2021;144:324-327.
    >> Share

  246. FRADLEY MG, Beckie TM, Brown SA, Cheng RK, et al
    Recognition, Prevention, and Management of Arrhythmias and Autonomic Disorders in Cardio-Oncology: A Scientific Statement From the American Heart Association.
    Circulation. 2021;144:e41-e55.
    >> Share

  247. FELKER GM, Butler J, Ibrahim NE, Pina IL, et al
    Implantable Cardioverter-Defibrillator Eligibility After Initiation of Sacubitril/Valsartan in Chronic Heart Failure: Insights From PROVE-HF.
    Circulation. 2021;144:180-182.
    >> Share

  248. VISKIN S, Marai I, Rosso R
    Long QT Syndrome and Torsade de Pointes Ultimately Treated With Quinidine: Introducing the Concept of Pseudo-Torsade de Pointes.
    Circulation. 2021;144:85-89.
    >> Share

    June 2021
  249. PASSMAN R
    "Pill-in-Pocket" Anticoagulation for Atrial Fibrillation: Fiction, Fact, or Foolish?
    Circulation. 2021;143:2211-2213.
    >> Share

  250. BHASIN D, Kumar R, Gupta A
    A Young Woman With Palpitations: A Poison or a Remedy?
    Circulation. 2021;143:2312-2315.
    >> Share

  251. BOULET J, Massie E, Liszkowski M
    A Silent Arrhythmia: How Would You Manage This Patient?
    Circulation. 2021;143:2205-2207.
    >> Share

    May 2021
  252. SINGH M, Joglar J
    Morbidly Obese Patients With Symptomatic Atrial Fibrillation: Why Are We Holding Back on Bariatric Surgery?
    Circulation. 2021;143:1838-1840.
    >> Share

  253. WALDMANN V, Combes N, Narayanan K, Marijon E, et al
    Response by Waldmann et al to Letter Regarding Article, "Long-Term Follow-Up of Patients With Tetralogy of Fallot and Implantable Cardioverter Defibrillator: The DAI-T4F Nationwide Registry".
    Circulation. 2021;143:e900-e901.
    >> Share

  254. FERRERO P, Chessa M
    Letter by Ferrero and Chessa Regarding Article, "Long-Term Follow-Up of Patients With Tetralogy of Fallot and Implantable Cardioverter Defibrillator: The DAI-T4F Nationwide Registry".
    Circulation. 2021;143:e898-e899.
    >> Share

    April 2021
  255. GILLIS AM, Wilton SB
    Rhythm Control of Atrial Fibrillation: The Earlier the Better?
    Circulation. 2021;143:1639-1641.
    >> Share

  256. KANEKO H, Yano Y, Itoh H, Morita K, et al
    Association of Blood Pressure Classification Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline with Risk of Heart Failure and Atrial Fibrillation.
    Circulation. 2021 Apr 22. doi: 10.1161/CIRCULATIONAHA.120.052624.
    >> Share

  257. RANSOM JL, Wong KC
    Palpitations in the Clinic.
    Circulation. 2021;143:1631-1634.
    >> Share

  258. BENZ AP, Hijazi Z, Lindback J, Connolly SJ, et al
    Biomarker-Based Risk Prediction With The ABC-AF Scores in Patients With Atrial Fibrillation Not Receiving Oral Anticoagulation.
    Circulation. 2021 Apr 14. doi: 10.1161/CIRCULATIONAHA.120.053100.
    >> Share

  259. DAI XC, An ZY
    Severe Arrhythmia Caused by a Chinese Herb Liquor: What Is the Diagnosis?
    Circulation. 2021;143:1450-1451.
    >> Share

    March 2021
  260. GIUDICESSI JR, Schram M, Bos JM, Galloway CD, et al
    Artificial Intelligence-Enabled Assessment of the Heart Rate Corrected QT Interval Using a Mobile Electrocardiogram Device.
    Circulation. 2021;143:1274-1286.
    >> Share

  261. ROSENBERG MA
    Trusting Magic: Interpretability of Predictions From Machine Learning Algorithms.
    Circulation. 2021;143:1299-1301.
    >> Share

  262. PENG D, Liu X, Pan Y
    Irregular Complex Tachycardia: Not Dual Atrioventricular Nodal Nonreentrant Tachycardia.
    Circulation. 2021;143:1173-1176.
    >> Share

  263. CONSTANT DIT BEAUFILS AL, Huttin O, Jobbe-Duval A, Senage T, et al
    Replacement Myocardial Fibrosis in Patients with Mitral Valve Prolapse: Relation to Mitral Regurgitation, Ventricular Remodeling and Arrhythmia.
    Circulation. 2021 Mar 12. doi: 10.1161/CIRCULATIONAHA.120.050214.
    >> Share

  264. PILLAI A, Ellenbogen KA, Padala SK
    A Tale of 2 Blocks.
    Circulation. 2021;143:1062-1065.
    >> Share

    February 2021
  265. ARAS D, Ozeke O, Topaloglu S
    When You Hear Hoofbeats, Look for Horses, Not Zebras.
    Circulation. 2021;143:862-864.
    >> Share

  266. WORKMAN V, Forrest JK, Enriquez A
    A Case of Presyncope After Transcatheter Aortic Valve Replacement.
    Circulation. 2021;143:857-861.
    >> Share

  267. YAMAGUCHI N, Xiao J, Narke D, Shaheen D, et al
    Cardiac Pressure Overload Decreases ETV1 Expression in the Left Atrium, Contributing to Atrial Electrical and Structural Remodeling.
    Circulation. 2021;143:805-820.
    >> Share

  268. KARABINOS I, Kostaki P, Panagopoulos Z
    Bizarre Downsloping ST Segment Elevation Challenge.
    Circulation. 2021;143:599-601.
    >> Share

  269. CHEN AY, Nishimura T, Tung R
    Narrowing the Differential Diagnosis for a Wide Complex Tachycardia.
    Circulation. 2021;143:503-506.
    >> Share

    January 2021
  270. TOMCSANYI J, Paulik R, Fresz T
    Acute Coronary Syndrome With Tall R Waves and Inverted T Waves in the Precordial Leads: An Ignored Entity.
    Circulation. 2021;143:397-400.
    >> Share

  271. KANAGASUNDRAM AN, Richardson TD, Stevenson WG
    The Heart Rate of Ventricular Tachycardia.
    Circulation. 2021;143:227-229.
    >> Share

  272. NISHIMURA T, Upadhyay GA, Aziz ZA, Beaser AD, et al
    Circuit Determinants of Ventricular Tachycardia Cycle Length: Characterization of Fast and Unstable Human Ventricular Tachycardia.
    Circulation. 2021;143:212-226.
    >> Share

  273. GOLD MR, Lambiase PD, El-Chami MF, Knops RE, et al
    Primary Results From the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) Trial.
    Circulation. 2021;143:7-17.
    >> Share

    December 2020
  274. PAL N, Padala S, Klein K
    Letter by Pal et al Regarding Article, "Impact of Left Atrial Appendage Exclusion on Short-Term Outcomes in Isolated Coronary Artery Bypass Graft Surgery".
    Circulation. 2020;142:e501-e502.
    >> Share

  275. BELLEY-COTE EP, Whitlock RP
    Letter by Belley-Cote and Whitlock Regarding Article, "Impact of Left Atrial Appendage Exclusion on Short-Term Outcomes in Isolated Coronary Artery Bypass Graft Surgery".
    Circulation. 2020;142:e503.
    >> Share

  276. MAHMOOD E, Sharkey A, Matyal R, Mahmood F, et al
    Response by Mahmood et al to Letter Regarding Article, "Impact of Left Atrial Appendage Exclusion on Short-Term Outcomes in Isolated Coronary Artery Bypass Graft Surgery".
    Circulation. 2020;142:e504-e505.
    >> Share

    October 2020
  277. MACONOCHIE IK, Aickin R, Hazinski MF, Atkins DL, et al
    Pediatric Life Support: 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.
    Circulation. 2020;142.
    >> Share

  278. BERG KM, Soar J, Andersen LW, Bottiger BW, et al
    Adult Advanced Life Support: 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.
    Circulation. 2020;142.
    >> Share

    June 2020
  279. MAHMOOD E, Matyal R, Mahmood F, Xu X, et al
    Impact of Left Atrial Appendage Exclusion on Short Term Outcomes In Isolated Coronary Artery Bypass Graft Surgery.
    Circulation. 2020 Jun 3. doi: 10.1161/CIRCULATIONAHA.119.044642.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016